Drug
Biochaperone Insulin Lispro
Biochaperone Insulin Lispro: highest development phase Phase 1, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| BioChaperone insulin lispro NCT02562313 | Phase 1 | Type 1 Diabetes Mellitus |
Latest
No recent events.
Follow Biochaperone Insulin Lispro on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.